Seeking Alpha

Conformis Highlights New Clinical Study Findings that Knee Shapes are Highly Individualized and are Not Determined by Identifiers, Including Gender, Body Type, or Ethnicity

BILLERICA, Mass., May 24, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (CFMS), a leading medical device company that features personalized knee and hip replacement products, today announced results of a ...
CNN

Conformis Achieves 100,000 Implant Milestone for Patient-Specific Knee Replacement Technology

BILLERICA, Mass., Jan. 30, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, ...
Seeking Alpha

Conformis Launches Patient Awareness Campaign to Highlight the Benefits of Personalized Knee Replacement Procedures

BILLERICA, Mass., March 21, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (CFMS) (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement products, recently ...
Nasdaq

Conformis iTotal® CR Knee Replacement System Awarded "7A" Performance Rating from the U.K.’s Orthopaedic Data Evaluation Panel

Independently verified assessment of the performance of the fully personalized iTotal CR system over a 7-year period confirms that it meets the panel’s demanding standards BILLERICA, Mass., Feb. 24, ...
MediaPost

Conformis Talks Personalized Knee Replacement In New Ad

Knee replacements are a fact of aging. Conformis, a Boston-based medical tech company, produced personalized joint replacement for knees and hips. The goal is less pain and faster recoveries. Eicoff ...
Nasdaq

Conformis Announces New Agreement with Vizient for Personalized Orthopedic Implants

Agreement enables interested Vizient members, including academic medical centers, acute care facilities, and ambulatory surgery centers (ASCs), to purchase Conformis knee and hip replacement solutions ...